hepat
c
viru
hcv
major
caus
chronic
liver
diseas
includ
steatosi
cirrhosi
hepatocellular
carcinoma
develop
transgen
mice
express
hcv
protein
success
repopul
scidalbupa
mice
human
hepatocyt
provid
import
tool
unravel
virushost
interact
vivo
sever
mous
model
exhibit
aspect
hcvrelat
liver
diseas
thu
vivo
model
play
import
role
understand
pathogenesi
hcv
infect
evalu
preclin
safeti
efficaci
new
antivir
compound
hcv
review
summar
import
mous
model
current
use
studi
hcv
pathogenesi
infect
final
perspect
model
futur
hcv
research
well
design
novel
small
anim
model
discuss
publish
elsevi
bv
behalf
european
associ
studi
liver
million
individu
worldwid
current
infect
hepat
c
viru
hcv
chronic
hcv
infect
frequent
result
seriou
liver
diseas
includ
steatosi
cirrhosi
hepatocellular
carcinoma
unit
state
hepat
c
lead
caus
orthotop
liver
transplant
unfortun
liver
transplant
cure
hepat
c
viral
recurr
invari
problem
lead
caus
graft
loss
vaccin
protect
hcv
infect
avail
current
antivir
therapi
character
limit
efficaci
high
cost
substanti
side
effect
hcv
posit
strand
rna
viru
classifi
genu
hepaciviru
flavivirida
translat
major
open
read
frame
hcv
genom
result
product
approxim
amino
acid
long
polyprotein
cleav
coand
posttransl
coordin
action
cellular
two
viral
proteas
function
subunit
core
c
envelop
nonstructur
protein
ns
hcv
replic
take
place
cytoplasm
host
cell
primarili
hepatocyt
recent
due
lack
cell
cultur
system
hcv
could
effici
propag
cultur
cell
support
molecular
studi
virushost
interact
robust
product
infecti
hcv
cell
cultur
final
achiev
use
uniqu
hcv
genom
deriv
blood
japanes
patient
fulmin
hepat
c
moreov
viru
particl
gener
clone
turn
infecti
vivo
chimpanze
mice
contain
human
liver
xenograft
introduc
multipl
adapt
mutat
use
dna
express
construct
infecti
hcv
genotyp
could
also
produc
cell
cultur
past
two
decad
chimpanze
pan
troglodyt
commonli
use
studi
mechan
acut
chronic
hcv
infect
studi
greatli
contribut
current
understand
hcv
infect
includ
immun
pathogenesi
review
see
howev
chimpanze
model
import
limit
hcvinfect
chimpanze
rare
develop
chronic
liver
diseas
extent
seen
hcvinfect
human
make
chimpanze
less
ideal
model
studi
mechan
hcv
pathogenesi
moreov
chimpanze
expens
difficult
handl
must
hous
care
appropri
nonhuman
primat
research
facil
sinc
chimpanze
list
endang
speci
limit
chimpanze
model
stimul
progress
toward
develop
altern
anim
model
hcv
research
although
hcv
infect
propag
mous
tissu
transgen
technolog
well
avail
mice
transplant
human
hepatocyt
made
laboratori
mous
attract
anim
model
hcv
research
articl
present
overview
current
mous
model
hcv
research
first
part
articl
focus
applic
transgen
mous
model
hcv
research
analysi
virushost
interact
second
part
summar
emerg
role
chimer
transgen
mice
popul
human
hepatocyt
studi
hcv
infect
conclud
present
futur
perspect
anim
model
hcv
research
field
transgen
anim
technolog
allow
germlin
insert
exogen
gene
alter
disrupt
endogen
gene
emerg
power
tool
vivo
analysi
gene
function
far
common
wellcharacter
approach
produc
transgen
mice
direct
pronuclear
microinject
transgen
onecel
fertil
embryo
typic
copi
exogen
transgen
integr
host
genom
appar
random
site
sever
group
establish
transgen
mice
express
hcv
protein
either
individu
togeth
polyprotein
studi
effect
protein
liver
patholog
hepat
steatosi
common
histolog
featur
chronic
hepat
c
steatosi
frequent
sever
patient
infect
hcv
genotyp
mechan
underli
genotyp
specif
steatosi
unknown
howev
hepat
steatosi
develop
secondari
obes
diabet
mellitu
alcohol
abus
protein
malnutrit
total
parenter
nutrit
acut
starvat
drug
therapi
number
transgen
mous
model
studi
indic
hcv
core
protein
suffici
induc
lipid
accumul
hepatocyt
review
see
core
protein
rnabind
protein
compon
viral
nucleocapsid
infect
cell
core
protein
found
associ
lipid
droplet
recent
studi
suggest
associ
core
protein
lipid
droplet
play
import
role
hcv
morphogenesi
effici
viru
product
base
experiment
model
transgen
mous
hcv
core
protein
seem
inhibit
microsom
triglycerid
transfer
protein
mtp
activ
rate
limit
enzym
hepat
lipoprotein
assembl
direct
like
consequ
inactiv
accumul
unsecret
triglycerid
henc
steatosi
moreov
hcv
core
protein
express
mous
liver
upregul
sterol
regulatori
element
bind
protein
promot
activ
transcript
factor
lead
upregul
enzym
involv
de
novo
lipogenesi
event
favor
intracellular
accumul
triglycerid
epidemiolog
clinic
virolog
data
shown
close
associ
chronic
hcv
infect
develop
hepatocellular
carcinoma
hcc
hcc
usual
aris
decad
infect
typic
context
underli
cirrhosi
use
transgen
mous
model
also
becom
evid
core
protein
hcv
oncogen
activ
liver
hcv
core
protein
constitut
express
liver
mice
strain
known
exhibit
spontan
occurr
hcc
rare
level
similar
found
chronic
hepat
c
patient
lead
multicentr
hepat
adenoma
develop
hcc
agedepend
manner
hcc
observ
predominantli
male
observ
consist
epidemiolog
data
men
chronic
infect
hcv
like
develop
hcc
transgen
mice
express
complet
hcv
polyprotein
show
increas
risk
cancer
suggest
hcv
protein
might
also
play
role
develop
hepatocarcinogenesi
diethylnitrosamin
den
base
model
hepatocarcinogenesi
transgen
mice
express
core
structur
protein
demonstr
acceler
tumor
growth
phenotyp
suggest
hcv
andor
possibl
conjunct
core
protein
act
tumor
enhanc
protein
howev
group
report
transgen
mice
express
hcv
core
protein
exhibit
patholog
phenotyp
liver
differ
may
relat
express
level
transgen
differ
genet
background
transgen
model
produc
address
role
hcv
nonstructur
protein
liver
patholog
transgen
mice
express
hcv
protein
gener
contrast
express
hcv
nonstructur
protein
caus
spontan
liver
patholog
base
experiment
model
transgen
mice
begin
understand
molecular
mechan
involv
develop
hcc
hepatocyt
prolifer
influenc
variou
factor
mitogen
chemic
cytokin
growth
factor
transcript
factor
one
activ
hcv
core
protein
implic
modifi
vivo
express
cytokin
inde
express
tumor
necrosi
factoralpha
tnfa
increas
protein
mrna
level
transgen
mice
constitut
express
hcv
core
protein
elev
concentr
tnfa
repres
characterist
featur
chronic
liver
diseas
liver
dysfunct
proinflammatori
stimuli
tnfa
induc
signal
cascad
cognat
receptor
activ
ijb
kinas
ikk
signalosom
subsequ
nfjb
major
regul
inflammatori
antiapoptot
gene
recent
luedd
et
al
demonstr
delet
ikk
subunit
nemoikkc
liver
parenchym
cell
caus
steatosi
hcc
mice
suggest
nfjb
activ
play
import
role
protect
liver
cancer
interestingli
vitro
experi
shown
hcv
core
protein
suppress
ikk
signalosom
activ
macrophag
addit
studi
necessari
determin
whether
hcv
core
protein
mediat
vivo
suppress
nfjb
activ
hepatocyt
lead
steatosi
hcc
experiment
data
transgen
mice
show
hcv
core
protein
bind
activ
dnabind
domain
retinoid
x
receptor
alpha
rxra
rxra
abundantli
express
liver
play
import
role
regul
cell
prolifer
differenti
well
lipid
metabol
furthermor
proteasom
activ
identifi
hcv
core
bind
protein
liver
hcv
coretransgen
mice
patient
chronic
hepat
c
interestingli
knockout
gene
hcv
coretransgen
mice
disrupt
develop
steatosi
hcc
suggest
activ
may
play
crucial
role
develop
liver
patholog
induc
hcv
infect
final
hcv
coretransgen
mice
demonstr
activ
peroxisom
proliferatorsactiv
receptor
ppara
subsequ
studi
show
ppara
essenti
hcv
core
proteininduc
hepat
steatosi
hcc
mice
ppara
regul
transcript
gene
encod
fatti
acidmetabol
enzym
variou
cellcycl
regul
oncogen
product
cyclin
cmyc
known
induc
pparadepend
manner
thu
modul
transcript
activ
hcv
core
protein
may
contribut
disturb
cell
prolifer
differenti
liver
lead
oncogen
potenti
oxid
stress
potenti
import
pathogen
mechan
chronic
liver
diseas
initi
promot
multistag
carcinogenesi
oxid
toxic
target
cell
also
overwhelm
cellular
antioxid
defens
neighbor
cell
lead
dna
damag
transgen
mice
express
hcv
core
alon
combin
hcv
show
elev
level
lipid
peroxid
oxid
damag
dna
oxid
stress
trigger
signal
transduc
activ
transcript
tyrosin
phosphoryl
expect
caus
signific
alter
cell
growth
properti
report
oncogen
final
studi
hcv
core
protein
transgen
mice
demonstr
express
hcv
core
protein
liver
convey
resist
autoimmun
liver
injuri
induc
cell
mitogen
concanavalin
consist
observ
hcv
coretransgen
hepatocyt
rel
resist
death
induc
antifa
tnfa
mediat
death
resist
associ
shift
activ
liver
tissu
find
indic
hcv
core
protein
may
protect
infect
hepatocyt
destruct
immun
system
promot
prolifer
similar
observ
report
transgen
mice
express
hcv
polyprotein
consist
constitut
express
hcv
protein
convent
transgen
mice
immunotoler
protein
thu
one
desir
goal
transgen
technolog
tempor
control
target
gene
express
specif
organ
creloxp
recombin
system
use
method
condit
gene
express
allow
spatial
celltyp
specif
tempor
inducerdepend
control
creloxp
system
two
compon
cre
recombinas
two
lox
p
site
cre
recogn
sitespecif
recombin
accomplish
cremedi
catalysi
reciproc
recombin
two
lox
p
site
tissuecultur
cell
mice
use
creloxpmedi
condit
express
system
wakita
colleagu
gener
hcv
transgen
mice
express
hcv
core
protein
hcv
transgen
express
liver
induc
intraven
administr
recombin
adenoviru
express
cre
recombinas
hcv
transgen
mice
regul
creloxp
switch
system
demonstr
anticor
antibodi
respons
hcvspecif
cell
respons
induct
core
transgen
express
interestingli
immun
respons
result
hepat
furthermor
machida
colleagu
use
creloxp
system
studi
effect
hcv
protein
fasmedi
cell
death
interestingli
transgen
express
hcv
transgen
mice
suppress
fasmedi
apoptot
cell
death
suggest
hcv
evad
innat
antivir
mechan
apoptosi
maintain
persist
infect
creloxp
switch
system
provid
use
nonimmun
toler
hcv
transgen
mous
model
allow
studi
host
immun
respons
hcv
protein
nonadenovir
gene
deliveri
method
cre
recombinas
futur
creloxp
hcv
mous
model
may
strengthen
applic
technolog
studi
hcvhost
interact
elimin
adenovirusrel
effect
potenti
strategi
could
product
hcv
transgen
mice
creloxp
switch
gene
express
system
control
tetracyclineinduc
express
system
transgen
mice
express
one
combin
hcv
protein
uniqu
irreplac
tool
elucid
understand
molecular
mechan
involv
hcvhost
interact
tabl
significantli
contribut
understand
hcv
host
interact
vivo
howev
sinc
mice
permiss
hcv
infect
result
obtain
transgen
mous
model
directli
applic
pathogenesi
hcv
infect
vivo
overcom
limit
chimer
transgen
mice
repopul
human
hepatocyt
develop
studi
hcv
infect
discoveri
hepatocyteleth
phenotyp
mice
carri
urokinasetyp
plasminogen
activ
transgen
control
albumin
promotor
albupa
complet
reconstitut
liver
mice
xenograft
rat
hepatocyt
laid
foundat
develop
small
anim
model
infect
hepat
b
c
virus
use
xenograft
human
hepatocyt
petersen
colleagu
elegantli
appli
upaxenograft
model
develop
hepat
b
mous
model
transplant
woodchuck
hepatocyt
albupa
mice
immunodefici
recombinant
activ
gene
background
repopul
woodchuck
hepatocyt
albupa
mice
lack
matur
b
lymphocyt
allow
product
infect
woodchuck
hepat
b
viru
three
year
later
mercer
et
al
demonstr
sever
combin
immunodefici
disord
scid
albupa
mous
engraft
primari
human
hepatocyt
infect
hcv
vivo
human
albumin
level
reliabl
marker
integr
function
statu
engraft
human
hepatocyt
success
transplant
mice
albumin
level
reach
plateau
approxim
mgml
around
week
human
hepatocyt
occupi
liver
parenchyma
show
sign
damag
degener
howev
transplant
liver
cell
demonstr
abund
accumul
glycogen
may
result
commun
failur
mous
ligand
receptor
human
counterpart
human
hepatocyt
stabli
engraft
scidalbupa
mous
anim
infect
human
hepatotroph
virus
includ
hepat
b
c
inocul
hcv
serum
hcv
patient
infect
chimpanze
hcv
produc
cell
cultur
hcvcc
caus
infect
viral
titer
blood
infect
mice
equal
higher
present
patient
chronic
hcv
infect
plasma
deriv
anim
use
infect
transplant
mice
mice
display
massiv
increas
viral
load
indic
hcv
infect
serial
passag
anim
vivo
hcv
infect
could
maintain
least
month
time
hcv
infect
alter
liver
function
architectur
howev
longterm
infect
studi
hcv
necessari
studi
cytopath
effect
hcv
infect
model
although
anim
model
requir
special
expertis
isol
transplant
human
hepatocyt
mainten
coloni
fragil
immunodefici
mice
approxim
mortal
newborn
current
best
avail
small
anim
model
studi
basic
biolog
hcv
furthermor
recent
studi
indic
model
allow
studi
antivir
activ
drug
neutral
antibodi
vivo
success
applic
scidalbupa
mous
model
drug
develop
shown
two
recent
public
investig
efficaci
interferon
ifna
hcv
proteas
inhibitor
treatment
ifna
appear
produc
similar
antivir
effect
hcv
infect
either
human
mous
model
exampl
day
therapi
hcv
titer
decreas
approxim
log
similar
impact
seen
clinic
trial
find
indic
scidalbupa
mous
model
hcv
antivir
treatment
respons
human
reason
accuraci
may
repres
valuabl
tool
studi
vivo
drug
metabol
preclin
evalu
candid
therapeut
addit
scidalbupa
mous
may
use
anim
model
evalu
preclin
toxic
new
antivir
compound
hcv
shown
manifest
wellcharacter
clinic
ultrastructur
sign
cardiotox
scidalbupa
mice
induc
antivir
biln
addit
human
scidalbupa
mous
model
success
use
studi
efficaci
neutral
antibodi
control
hcv
infect
use
model
law
colleagu
demonstr
human
monoclon
antibodi
abl
neutral
genet
divers
hcv
isol
protect
heterolog
hcv
quasispeci
challeng
result
provid
evid
broadli
neutral
antibodi
hcv
protect
heterolog
viral
infect
suggest
prophylact
vaccin
hcv
may
achiev
vanwolleghem
colleagu
also
address
question
whether
igg
neutral
properti
chronic
infect
patient
prevent
de
novo
hcv
infect
vivo
author
demonstr
evid
scidalbupa
mous
model
use
passiv
immun
studi
hcv
polyclon
igg
patient
chronic
infect
hcv
convey
vivo
steril
immun
homolog
nonmut
ancestr
hepat
c
viru
chronic
hcv
infect
result
highli
variabl
cours
liver
diseas
rang
mild
inflamm
rapidli
progress
fibrosi
cirrhosi
hcc
suggest
host
factor
play
import
role
infect
outcom
viral
pathogenesi
scidalbupa
mous
model
provid
uniqu
system
analyz
hostspecif
respons
hcv
anim
transplant
hepatocyt
differ
donor
inocul
singl
sourc
hcv
transcript
profil
hcvinduc
gene
express
chang
scidalbupa
mous
model
demonstr
anim
contain
hepatocyt
donor
show
similar
respons
anim
contain
hepatocyt
differ
donor
exampl
hcvinfect
anim
show
activ
host
innat
antivir
signal
pathway
respons
highli
variabl
number
intens
interferon
ifn
stimul
gene
indic
host
factor
may
influenc
effect
innat
immun
respons
lack
adapt
immun
respons
anim
make
possibl
distinguish
viralmedi
immunemedi
effect
host
gene
express
thu
scidalbupa
mous
model
valuabl
tool
investig
role
host
factor
develop
liver
diseas
use
studi
aspect
innat
antivir
immun
respons
may
play
fundament
role
limit
hcv
replic
potenti
infect
chimer
mice
recombin
tissuecultur
deriv
hcv
broaden
scope
applic
fig
recent
liver
repopul
human
hepatocyt
demonstr
sever
immunodefici
fumarylacetoacet
hydrolas
fah
defici
mous
model
engraft
human
hepatocyt
serial
transplant
primari
donor
allow
expans
human
hepatocyt
donor
sever
gener
recipi
mice
studi
need
determin
whether
model
use
studi
hcv
infect
superior
upabas
model
appropri
anim
model
essenti
studi
human
diseas
develop
therapeut
strategi
test
drug
safeti
transgen
mice
express
hcv
protein
shown
play
import
role
elucid
molecular
mechan
hcvhost
interact
hcvrelat
liver
patholog
sinc
steatosi
hcc
relev
clinic
manifest
seen
hcvinfect
individu
transgen
mous
model
metabol
similar
human
need
first
unlik
human
mous
primari
circul
lipoprotein
hdl
second
wherea
human
liver
produc
mous
liver
produc
truncat
form
also
cetp
plasma
glycoprotein
facilit
transfer
cholesteryl
ester
hdl
apobcontain
lipoprotein
vldl
ldl
present
human
mice
review
see
develop
hcv
transgen
mice
humanlik
lipid
metabol
may
help
better
understand
impact
viral
protein
pathogenesi
liver
diseas
well
develop
character
antivir
futur
ideal
mous
model
would
mous
permiss
hcv
infect
host
cell
surfac
receptor
recogn
import
determin
virushost
rang
tissu
tropism
hcvreceptor
interact
multistep
process
viru
use
sever
bind
entri
receptor
simultan
sequenti
enter
host
cell
review
see
interest
note
although
hcv
infect
mous
hepatocyt
replic
hcv
prototyp
strain
mous
hepatoma
cell
line
report
one
futur
strategi
overcom
speci
barrier
studi
hcv
infect
would
establish
transgen
mous
line
express
human
hcvreceptor
molecul
sever
acut
respiratori
syndrom
sar
coronaviru
infect
develop
transgen
mous
line
express
human
angiotensinconvert
enzym
demonstr
suitabl
model
studi
sar
infect
mice
tetraspanin
propos
play
role
hcv
entri
review
see
howev
transgen
mice
express
human
liver
confer
suscept
hcv
infect
suggest
human
cellular
factor
requir
hcv
infect
mous
thu
develop
permiss
hcv
mous
model
may
requir
coexpress
sever
human
hcv
entri
molecul
human
liver
specif
heparan
sulfat
scaveng
receptor
class
b
type
claudin
well
yet
identifi
host
factor
restrict
hcv
tropism
human
hepatocyt
final
hcv
permiss
mous
model
reconstitut
human
immun
system
would
allow
us
studi
mechan
hcv
immunopathogenesi
c
mice
doubl
knockout
mice
nonobes
receptor
gamma
chainknockedout
mice
develop
function
human
immun
system
human
hematopoiet
stem
cell
demonstr
mous
model
valuabl
tool
studi
hiv
infect
pathogenesi
could
conceiv
adopt
studi
immunopathogenesi
hcv
infect
mous
model
